心源性休克患者接受机械循环支持时的血流动力学监测价值
本文综述了心源性休克(CS)及机械循环支持期间经肺动脉导管(PAC)获得的血流动力学指标,指出PAC可指导治疗优化,但既往关于PAC获益的研究结论不一且缺乏随机对照试验,强调标准化监测可改善决策与结局。
要点
- PAC监测可指导心源性休克患者机械循环支持期间的治决策。
- 关于PAC获益的研究结论不一致,且缺乏在CS患者中的随机对照试验。
- 标准化血流动力学监测方法可能改善患者结局。
核心结论
- 肺动脉导管监测可为接受机械循环支持的心源性休克患者提供血流动力学指导,但需标准化方法并等待随机对照试验验证。
研究设计与样本
- 综述,总结心源性休克与机械循环支持相关的肺动脉导管血流动力学测量。
主要发现
- 关于肺动脉导管获益的多个研究结论不明确,导致临床使用存在差异。
- 肺动脉导管使用尚未在心源性休克患者(伴或不伴机械循环支持)中作为随机对照试验的一部分进行研究。
临床怎么用
- 对接受机械循环支持的心源性休克患者,可考虑使用肺动脉导管进行血流动力学监测以指导治疗优化。
局限性
- 缺乏针对心源性休克患者使用肺动脉导管的随机对照试验证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The recent widespread availability and use of mechanical circulatory support is transforming the management and outcomes of cardiogenic shock (CS). Clinical decision-making regarding the optimization of therapies for patients with CS can be guided effectively by hemodynamic monitoring with a pulmonary artery catheter (PAC). Because several studies regarding the benefit of PACs are ambiguous, the use of PACs is variable among clinicians treating patients with CS. More notable is that PAC use has not been studied as part of a randomized, controlled trial in patients with CS with or without mechanical circulatory support. Standardized approaches to hemodynamic monitoring in these patients can improve decision-making and outcomes. In this review, we summarize the hemodynamics of CS and mechanical circulatory support with PAC-derived measurements, and provide a compelling rationale for the use of PAC monitoring in patients with CS receiving mechanical circulatory support.
引用
- Saxena A, Garan AR, Kapur NK, et al. Value of Hemodynamic Monitoring in Patients With Cardiogenic Shock Undergoing Mechanical Circulatory Support. Circulation. 2020. PMID: 32250695. doi:10.1161/CIRCULATIONAHA.119.043080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。